Flupirtine Maleate 100 mg + Paracetamol 325 mg Uncoated Bilayered Tablet

Flupirtine Maleate 100 mg + Paracetamol 325 mg Uncoated Bilayered Tablet is a uncoated bilayered tablet formulated with Flupirtine Maleate 100 mg + Paracetamol 325 mg. The active ingredient profile is Flupirtine Maleate; Paracetamol, placing the product in the analgesic combination category. Flupirtine is an analgesic medicine whose availability has been restricted or withdrawn in multiple markets because of safety concerns. The bilayered presentation separates formulation layers within the same tablet; any release characteristics must match the approved finished-product specification. For website cataloguing, composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. The description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and the prescriber’s judgement. Prescription status, precautions, interactions, adverse effects and dosing must be checked against the current approved product label before publication. Manufacturer, licence, storage, shelf-life, pack configuration and market-specific regulatory details should be added only from verified product documentation.